Ashleigh Philp

Dr. Ashleigh Philp


Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
APAshleigh Philp
Ashleigh Philp
SBSam Butterworth
Sam Butterworth
EDEdward T Davis
Edward T Davis
SJSimon W Jones
Simon W Jones
Obesity increases the risk of hip osteoarthritis (OA). Recent studies have shown that adipokine extracellular nicotinamide phosphoribosyltransferase (eNAMPT or visfatin) induces the production of IL-6 and matrix metalloproteases (MMPs) in chondrocytes, suggesting it may promote articular cartilage degradation. However, neither the functional effects of extracellular visfatin on human articular cartilage tissue, nor its expression in the joint of hip OA patients of varying BMI, have been reported. Hip OA joint tissues were collected from patients undergoing joint replacement surgery. Cartilage explants were stimulated with recombinant human visfatin. Pro-inflammatory cytokines and MMPs were measured by ELISA and Luminex. Localisation of visfatin expression in cartilage tissue was determined by immunohistochemistry. Cartilage matrix degradation was determined by quantifying proteoglycan release. Expression of visfatin was elevated in the synovial tissue of hip OA patients who were obese, and was co-localised with MMP-13 in areas of cartilage damage. Visfatin promoted the degradation of hip OA cartilage proteoglycan and induced the production of pro-inflammatory cytokines (IL-6, MCP-1, CCL20, and CCL4) and MMPs. The elevated expression of visfatin in the obese hip OA joint, and its functional effects on hip cartilage tissue, suggests it plays a central role in the loss of cartilage integrity in obese patients with hip OA.

12 May 2025 in Transplantation Direct
Verified
Journal Article
Open access
EMEisa Tahmasbpour Marzouni
Eisa Tahmasbpour Marzouni
APAshleigh Philp
Ashleigh Philp
VSVanathi Sivasubramaniam
Vanathi Sivasubramaniam
CTClaire Thomson
Claire Thomson
MPMarshall Plit
Marshall Plit
DDDavid Darley
David Darley
Background.: Chronic lung allograft dysfunction (CLAD) is a major contributor to poor long-term survival after lung transplantation (LTx). There is a paucity of validated tissue biomarkers which limits the early detection of CLAD. The aim of this study was to discover novel tissue proteins in CLAD. Methods.: A longitudinal cohort study analyzed 15 tissue specimens from 2 groups of bilateral LTx recipients; those with CLAD (n = 3) and those without CLAD (n = 3). In both groups, transbronchial biopsies (TBBx) were retrieved from 2 timepoints; stable surveillance at 90 d after transplant, and during episodes of acute lung allograft dysfunction. In the CLAD cohort, additional tissue from explant CLAD lungs collected at retransplantation was analyzed. Proteomics analysis and immunohistochemistry were used to identify and validate differentially expressed proteins. Results.: Tissue upregulation of a number of proteins including SerpinB1, SerpinH1, Cofilin 1, MUC1, COL15A1, COL4A4, and Coronin1B was found in recipients with CLAD. This finding was present when comparing CLAD onset and explant pathology to stable surveillance among recipients with CLAD and evident when compared with recipients without CLAD. Most of the upregulated tissue proteins in patients with CLAD had collectively critical roles in leukocytes migration and activation, inflammation, free radicals production and oxidative stress, epithelial–mesenchymal transition, myofibroblasts activation, and excessive deposition of extracellular matrix, which in turn enhance the risk of lung fibrosis and graft rejection. We also found exclusive expression of HLA-DQB1, JCHAIN, SAP18, FUCA1, MZB1, G3BP2, and BTF3 in CLAD cases, indicating they could be specific biomarkers of CLAD. Conclusions.: This study identifies distinct proteomes that are linked to CLAD development and consequently may be a useful indicator for identifying LTx patients at higher risk of CLAD.

16 May 2023 in Function
Verified
Journal Article
Open access
PDF file
CPCamila Padilha
Camila Padilha
APAshleigh Philp
Ashleigh Philp
Camila Padilha, Ashleigh M Philp; A Perspective on “Hypoxia Resistance Is An Inherent Phenotype of The Mouse Flexor Digitorum Brevis Skeletal Muscle”, Function,

26 June 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
BSBen Stocks
Ben Stocks
SAStephen P. Ashcroft
Stephen P. Ashcroft
SJSophie Joanisse
Sophie Joanisse
YEYasir S. Elhassan
Yasir S. Elhassan
GLGareth G. Lavery
Gareth G. Lavery
APAndrew Philp
Andrew Philp
Oral supplementation of the NAD + precursor Nicotinamide Riboside (NR) has been reported to increase Sirtuin (SIRT) signalling, mitochondrial biogenesis and endurance capacity in rodent skeletal muscle. However, whether NR supplementation can elicit a similar response in human skeletal muscle is unclear. This study aimed to assess the effect of 7-day NR supplementation on exercise-induced transduction and transcriptional responses in skeletal muscle of young, healthy, recreationally active human volunteers. In a double-blinded, randomised, counter-balanced, crossover design, eight male participants (age: 23 ± 4 years, VO 2 peak: 46.5 ± 4.4 mL·kg -1 ·min -1 ) received one week of NR or cellulose placebo (PLA) supplementation (1000 mg·d -1 ) before performing one hour of cycling at 60% Wmax. Muscle biopsies were collected prior to supplementation and pre-, immediately and three-hours post-exercise from the medial vastus lateralis, whilst venous blood samples were collected throughout the trial. Global acetylation, auto-PARylation of PARP1, acetylation of p53 Lys382 and MnSOD Lys122 were unaffected by NR supplementation or exercise. Exercise led to an increase in AMPK Thr172 (1.6-fold), and ACC Ser79 (4-fold) phosphorylation, in addition to an increase in PGC-1α (∼5-fold) and PDK4 (∼10-fold) mRNA expression, however NR had no additional effect on this response. There was also no effect of NR supplementation on substrate utilisation at rest or during exercise or on skeletal muscle mitochondrial respiration. Finally, NR supplementation blunted the exercise induced activation of skeletal muscle NNMT mRNA expression, but had no effect on mRNA expression of NMRK1, NAMPT or NMNAT1, which were not significantly affected by NR supplementation or exercise. In summary, one week of NR supplementation does not augment skeletal muscle signal transduction pathways implicated in mitochondrial adaptation to endurance exercise.

16 May 2020 in bioRxiv
Verified
Preprint
Open access
PDF file
SAStephen P. Ashcroft
Stephen P. Ashcroft
GFGareth Fletcher
Gareth Fletcher
APAshleigh Philp
Ashleigh Philp
Philip AthertonPhilip Atherton
Philip Atherton
APAndrew Philp
Andrew Philp
Vitamin D deficiency is known to be associated with symptoms of skeletal muscle myopathy including muscle weakness and fatigue. Recently, vitamin D related metabolites have been linked to the maintenance of mitochondrial function within skeletal muscle. However, current evidence is limited to in vitro models and the effects of diet-induced vitamin D deficiency upon skeletal muscle mitochondrial function in vivo have received little attention. In order to examine the role of vitamin D in the maintenance of mitochondrial function in vivo , we utilised an established model of diet-induced vitamin D deficiency in C57BL/6J mice. Mice were fed either a control (2,200 IU/kg) or a vitamin D deplete (0 IU/kg) diet for periods of 1-, 2- and 3-months. Skeletal muscle mitochondrial function and ADP sensitivity were assessed via high-resolution respirometry and mitochondrial protein content via immunoblotting. As a result of 3-month of diet-induced vitamin D deficiency, respiration supported via CI+II P and ETC were 35% and 37% lower when compared to vitamin D replete mice ( P < 0.05). Despite functional alterations, the protein expression of electron transfer chain subunits remained unchanged in response to dietary intervention ( P > 0.05). In conclusion, we report that 3-months of diet-induced vitamin D deficiency reduced skeletal muscle mitochondrial function in C57BL/6J mice. Our data, when combined with previous in vitro observations, suggests that vitamin D mediated regulation of mitochondrial function may underlie the exacerbated muscle fatigue and performance deficits observed during vitamin D deficiency.